GL1X · GenesisL1 explorer

MolNFT v1 · #102146 · protein

Crystal structure of human Fab CAP256-VRC26.07, a potent V1V2-directed HIV-1 neutralizing antibody

4OD3 · CAP256-VRC26.07 light chain: “Crystal structure of human Fab CAP256-VRC26.07, a potent V1V2-directed HIV-1 neutralizing antibody”. X-ray diffraction, 1 ligand (ZN), 3 pockets (best druggability 0.69). MolNFT v1 #102146 on GenesisL1…

PDB
4OD3
Type
protein
Length
447 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CAP256-VRC26.07 light chain; CAP256-VRC26.07 heavy chain
Ligands
ZN
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LCAP256-VRC26.07 light chainprotein2138% helix, 46% strand—
HCAP256-VRC26.07 heavy chainprotein2346% helix, 50% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains L, H
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17770.690.7678empty
22370.520.7639empty
3630.350.7816empty

Interfaces

1 interface between chains.

  • L–H · 1821 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 4OD3 · Crystal structure of human Fab CAP256-VRC26.07, a potent V1V2-directed HIV-1 neutralizing… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.